nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—HTR3A—Memantine—Alzheimer's disease	0.506	0.686	CbGbCtD
Alosetron—CYP2C9—Donepezil—Alzheimer's disease	0.0862	0.117	CbGbCtD
Alosetron—CYP3A4—Rivastigmine—Alzheimer's disease	0.0627	0.0851	CbGbCtD
Alosetron—CYP3A4—Donepezil—Alzheimer's disease	0.0501	0.068	CbGbCtD
Alosetron—CYP3A4—Galantamine—Alzheimer's disease	0.0323	0.0438	CbGbCtD
Alosetron—Feeling of body temperature change—Memantine—Alzheimer's disease	0.00905	0.0392	CcSEcCtD
Alosetron—Muscle stiffness—Rivastigmine—Alzheimer's disease	0.00625	0.0271	CcSEcCtD
Alosetron—Diverticulitis—Galantamine—Alzheimer's disease	0.00534	0.0232	CcSEcCtD
Alosetron—Feeling cold—Donepezil—Alzheimer's disease	0.00472	0.0205	CcSEcCtD
Alosetron—Diverticulitis—Donepezil—Alzheimer's disease	0.00414	0.0179	CcSEcCtD
Alosetron—Cognitive disorder—Galantamine—Alzheimer's disease	0.00403	0.0175	CcSEcCtD
Alosetron—Diverticulitis—Memantine—Alzheimer's disease	0.00376	0.0163	CcSEcCtD
Alosetron—Diverticulitis—Rivastigmine—Alzheimer's disease	0.00368	0.0159	CcSEcCtD
Alosetron—Cognitive disorder—Memantine—Alzheimer's disease	0.00283	0.0123	CcSEcCtD
Alosetron—Trauma—Rivastigmine—Alzheimer's disease	0.00252	0.0109	CcSEcCtD
Alosetron—Cholecystitis—Donepezil—Alzheimer's disease	0.00235	0.0102	CcSEcCtD
Alosetron—Muscle rigidity—Rivastigmine—Alzheimer's disease	0.00234	0.0102	CcSEcCtD
Alosetron—Haemorrhoids—Donepezil—Alzheimer's disease	0.0023	0.00995	CcSEcCtD
Alosetron—Balance disorder—Memantine—Alzheimer's disease	0.00224	0.00972	CcSEcCtD
Alosetron—Balance disorder—Rivastigmine—Alzheimer's disease	0.00219	0.0095	CcSEcCtD
Alosetron—Cholecystitis—Rivastigmine—Alzheimer's disease	0.00209	0.00905	CcSEcCtD
Alosetron—Haemorrhoids—Memantine—Alzheimer's disease	0.00208	0.00903	CcSEcCtD
Alosetron—Haemorrhoids—Rivastigmine—Alzheimer's disease	0.00204	0.00884	CcSEcCtD
Alosetron—Haematoma—Memantine—Alzheimer's disease	0.00195	0.00845	CcSEcCtD
Alosetron—Haematoma—Rivastigmine—Alzheimer's disease	0.00191	0.00827	CcSEcCtD
Alosetron—Ileus—Donepezil—Alzheimer's disease	0.00191	0.00826	CcSEcCtD
Alosetron—Ondansetron—CYP2D6—Alzheimer's disease	0.00186	1	CrCbGaD
Alosetron—Nail disorder—Rivastigmine—Alzheimer's disease	0.00185	0.00801	CcSEcCtD
Alosetron—Bone pain—Galantamine—Alzheimer's disease	0.00182	0.00788	CcSEcCtD
Alosetron—Menstrual disorder—Memantine—Alzheimer's disease	0.0018	0.00779	CcSEcCtD
Alosetron—Fungal infection—Donepezil—Alzheimer's disease	0.00175	0.00758	CcSEcCtD
Alosetron—Ileus—Memantine—Alzheimer's disease	0.00173	0.0075	CcSEcCtD
Alosetron—Cystitis noninfective—Galantamine—Alzheimer's disease	0.0017	0.00737	CcSEcCtD
Alosetron—Laryngitis—Memantine—Alzheimer's disease	0.0017	0.00737	CcSEcCtD
Alosetron—Cystitis—Galantamine—Alzheimer's disease	0.00168	0.00729	CcSEcCtD
Alosetron—Laryngitis—Rivastigmine—Alzheimer's disease	0.00166	0.00721	CcSEcCtD
Alosetron—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00162	0.00702	CcSEcCtD
Alosetron—Fungal infection—Memantine—Alzheimer's disease	0.00159	0.00688	CcSEcCtD
Alosetron—Bladder pain—Galantamine—Alzheimer's disease	0.00157	0.00682	CcSEcCtD
Alosetron—Fungal infection—Rivastigmine—Alzheimer's disease	0.00155	0.00673	CcSEcCtD
Alosetron—Contusion—Donepezil—Alzheimer's disease	0.00155	0.0067	CcSEcCtD
Alosetron—Extrasystoles—Memantine—Alzheimer's disease	0.00146	0.00631	CcSEcCtD
Alosetron—Gastroenteritis—Galantamine—Alzheimer's disease	0.00143	0.00618	CcSEcCtD
Alosetron—Extrasystoles—Rivastigmine—Alzheimer's disease	0.00142	0.00618	CcSEcCtD
Alosetron—Injury—Galantamine—Alzheimer's disease	0.00138	0.00596	CcSEcCtD
Alosetron—Musculoskeletal stiffness—Rivastigmine—Alzheimer's disease	0.00134	0.00579	CcSEcCtD
Alosetron—Abnormal dreams—Donepezil—Alzheimer's disease	0.00133	0.00578	CcSEcCtD
Alosetron—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00132	0.00571	CcSEcCtD
Alosetron—Cystitis—Donepezil—Alzheimer's disease	0.0013	0.00565	CcSEcCtD
Alosetron—Bone pain—Memantine—Alzheimer's disease	0.00128	0.00554	CcSEcCtD
Alosetron—Bone pain—Rivastigmine—Alzheimer's disease	0.00125	0.00542	CcSEcCtD
Alosetron—Bladder pain—Donepezil—Alzheimer's disease	0.00122	0.00529	CcSEcCtD
Alosetron—Cystitis noninfective—Memantine—Alzheimer's disease	0.0012	0.00519	CcSEcCtD
Alosetron—Cystitis—Memantine—Alzheimer's disease	0.00118	0.00513	CcSEcCtD
Alosetron—Colitis—Memantine—Alzheimer's disease	0.00118	0.0051	CcSEcCtD
Alosetron—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.00117	0.00508	CcSEcCtD
Alosetron—Cystitis—Rivastigmine—Alzheimer's disease	0.00116	0.00502	CcSEcCtD
Alosetron—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00115	0.005	CcSEcCtD
Alosetron—Colitis—Rivastigmine—Alzheimer's disease	0.00115	0.00499	CcSEcCtD
Alosetron—Gastritis—Galantamine—Alzheimer's disease	0.00112	0.00485	CcSEcCtD
Alosetron—Bladder pain—Memantine—Alzheimer's disease	0.00111	0.0048	CcSEcCtD
Alosetron—Urine output increased—Memantine—Alzheimer's disease	0.00111	0.0048	CcSEcCtD
Alosetron—Gastroenteritis—Donepezil—Alzheimer's disease	0.00111	0.00479	CcSEcCtD
Alosetron—Eczema—Donepezil—Alzheimer's disease	0.00109	0.00473	CcSEcCtD
Alosetron—Bladder pain—Rivastigmine—Alzheimer's disease	0.00108	0.0047	CcSEcCtD
Alosetron—Urine output increased—Rivastigmine—Alzheimer's disease	0.00108	0.0047	CcSEcCtD
Alosetron—Injury—Donepezil—Alzheimer's disease	0.00107	0.00462	CcSEcCtD
Alosetron—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00105	0.00454	CcSEcCtD
Alosetron—Sleep disorder—Memantine—Alzheimer's disease	0.00103	0.00445	CcSEcCtD
Alosetron—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00102	0.0044	CcSEcCtD
Alosetron—Polyuria—Memantine—Alzheimer's disease	0.00101	0.00439	CcSEcCtD
Alosetron—Pollakiuria—Galantamine—Alzheimer's disease	0.00101	0.00437	CcSEcCtD
Alosetron—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00101	0.00436	CcSEcCtD
Alosetron—Hypoglycaemia—Donepezil—Alzheimer's disease	0.001	0.00435	CcSEcCtD
Alosetron—Gastroenteritis—Memantine—Alzheimer's disease	0.001	0.00435	CcSEcCtD
Alosetron—Polyuria—Rivastigmine—Alzheimer's disease	0.000991	0.0043	CcSEcCtD
Alosetron—Eczema—Memantine—Alzheimer's disease	0.00099	0.00429	CcSEcCtD
Alosetron—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000985	0.00427	CcSEcCtD
Alosetron—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.000982	0.00426	CcSEcCtD
Alosetron—Depression—Galantamine—Alzheimer's disease	0.000971	0.00421	CcSEcCtD
Alosetron—Eczema—Rivastigmine—Alzheimer's disease	0.000968	0.0042	CcSEcCtD
Alosetron—Injury—Memantine—Alzheimer's disease	0.000968	0.00419	CcSEcCtD
Alosetron—Urinary tract infection—Galantamine—Alzheimer's disease	0.000947	0.0041	CcSEcCtD
Alosetron—Injury—Rivastigmine—Alzheimer's disease	0.000947	0.0041	CcSEcCtD
Alosetron—Hypoglycaemia—Memantine—Alzheimer's disease	0.000911	0.00395	CcSEcCtD
Alosetron—Abdominal pain upper—Donepezil—Alzheimer's disease	0.000895	0.00388	CcSEcCtD
Alosetron—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.000892	0.00386	CcSEcCtD
Alosetron—Cramp muscle—Donepezil—Alzheimer's disease	0.000882	0.00382	CcSEcCtD
Alosetron—Haemoglobin—Galantamine—Alzheimer's disease	0.000879	0.00381	CcSEcCtD
Alosetron—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000876	0.0038	CcSEcCtD
Alosetron—Haemorrhage—Galantamine—Alzheimer's disease	0.000874	0.00379	CcSEcCtD
Alosetron—Hepatitis—Galantamine—Alzheimer's disease	0.000874	0.00379	CcSEcCtD
Alosetron—Gastritis—Donepezil—Alzheimer's disease	0.000867	0.00376	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000864	0.00375	CcSEcCtD
Alosetron—Abdominal distension—Donepezil—Alzheimer's disease	0.000852	0.00369	CcSEcCtD
Alosetron—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000812	0.00352	CcSEcCtD
Alosetron—Nasopharyngitis—Memantine—Alzheimer's disease	0.000795	0.00345	CcSEcCtD
Alosetron—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000795	0.00344	CcSEcCtD
Alosetron—Gastritis—Memantine—Alzheimer's disease	0.000787	0.00341	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000784	0.0034	CcSEcCtD
Alosetron—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000784	0.0034	CcSEcCtD
Alosetron—Pollakiuria—Donepezil—Alzheimer's disease	0.000782	0.00339	CcSEcCtD
Alosetron—Arrhythmia—Galantamine—Alzheimer's disease	0.000781	0.00339	CcSEcCtD
Alosetron—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000778	0.00337	CcSEcCtD
Alosetron—Gastritis—Rivastigmine—Alzheimer's disease	0.00077	0.00334	CcSEcCtD
Alosetron—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000764	0.00331	CcSEcCtD
Alosetron—Depression—Donepezil—Alzheimer's disease	0.000753	0.00326	CcSEcCtD
Alosetron—Flatulence—Galantamine—Alzheimer's disease	0.00075	0.00325	CcSEcCtD
Alosetron—Jaundice—Donepezil—Alzheimer's disease	0.000736	0.00319	CcSEcCtD
Alosetron—Urinary tract infection—Donepezil—Alzheimer's disease	0.000734	0.00318	CcSEcCtD
Alosetron—Muscle spasms—Galantamine—Alzheimer's disease	0.000732	0.00317	CcSEcCtD
Alosetron—Sweating—Donepezil—Alzheimer's disease	0.000724	0.00314	CcSEcCtD
Alosetron—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000714	0.0031	CcSEcCtD
Alosetron—Tremor—Galantamine—Alzheimer's disease	0.000713	0.00309	CcSEcCtD
Alosetron—Pollakiuria—Memantine—Alzheimer's disease	0.00071	0.00308	CcSEcCtD
Alosetron—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000706	0.00306	CcSEcCtD
Alosetron—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000699	0.00303	CcSEcCtD
Alosetron—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000695	0.00301	CcSEcCtD
Alosetron—Hyperglycaemia—Memantine—Alzheimer's disease	0.000693	0.00301	CcSEcCtD
Alosetron—Malaise—Galantamine—Alzheimer's disease	0.000686	0.00298	CcSEcCtD
Alosetron—Depression—Memantine—Alzheimer's disease	0.000683	0.00296	CcSEcCtD
Alosetron—Haemoglobin—Donepezil—Alzheimer's disease	0.000681	0.00295	CcSEcCtD
Alosetron—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000678	0.00294	CcSEcCtD
Alosetron—Hepatitis—Donepezil—Alzheimer's disease	0.000678	0.00294	CcSEcCtD
Alosetron—Haemorrhage—Donepezil—Alzheimer's disease	0.000678	0.00294	CcSEcCtD
Alosetron—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000674	0.00292	CcSEcCtD
Alosetron—Depression—Rivastigmine—Alzheimer's disease	0.000669	0.0029	CcSEcCtD
Alosetron—Urinary tract infection—Memantine—Alzheimer's disease	0.000666	0.00289	CcSEcCtD
Alosetron—Cough—Galantamine—Alzheimer's disease	0.000664	0.00288	CcSEcCtD
Alosetron—Hypertension—Galantamine—Alzheimer's disease	0.000657	0.00285	CcSEcCtD
Alosetron—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000652	0.00283	CcSEcCtD
Alosetron—Myalgia—Galantamine—Alzheimer's disease	0.000648	0.00281	CcSEcCtD
Alosetron—Anxiety—Galantamine—Alzheimer's disease	0.000646	0.0028	CcSEcCtD
Alosetron—Sinusitis—Memantine—Alzheimer's disease	0.000643	0.00279	CcSEcCtD
Alosetron—Sweating—Rivastigmine—Alzheimer's disease	0.000643	0.00279	CcSEcCtD
Alosetron—Discomfort—Galantamine—Alzheimer's disease	0.00064	0.00278	CcSEcCtD
Alosetron—Dry mouth—Galantamine—Alzheimer's disease	0.000634	0.00275	CcSEcCtD
Alosetron—Sinusitis—Rivastigmine—Alzheimer's disease	0.000629	0.00273	CcSEcCtD
Alosetron—Confusional state—Galantamine—Alzheimer's disease	0.000626	0.00272	CcSEcCtD
Alosetron—Haemoglobin—Memantine—Alzheimer's disease	0.000618	0.00268	CcSEcCtD
Alosetron—Haemorrhage—Memantine—Alzheimer's disease	0.000615	0.00267	CcSEcCtD
Alosetron—Hepatitis—Memantine—Alzheimer's disease	0.000615	0.00267	CcSEcCtD
Alosetron—Hypoaesthesia—Memantine—Alzheimer's disease	0.000612	0.00265	CcSEcCtD
Alosetron—Arrhythmia—Donepezil—Alzheimer's disease	0.000605	0.00262	CcSEcCtD
Alosetron—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000605	0.00262	CcSEcCtD
Alosetron—Skin disorder—Galantamine—Alzheimer's disease	0.000603	0.00262	CcSEcCtD
Alosetron—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000602	0.00261	CcSEcCtD
Alosetron—Hepatitis—Rivastigmine—Alzheimer's disease	0.000602	0.00261	CcSEcCtD
Alosetron—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000601	0.0026	CcSEcCtD
Alosetron—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000599	0.0026	CcSEcCtD
Alosetron—Alopecia—Donepezil—Alzheimer's disease	0.000599	0.0026	CcSEcCtD
Alosetron—Flatulence—Donepezil—Alzheimer's disease	0.000581	0.00252	CcSEcCtD
Alosetron—Muscle spasms—Donepezil—Alzheimer's disease	0.000567	0.00246	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000566	0.00245	CcSEcCtD
Alosetron—Tremor—Donepezil—Alzheimer's disease	0.000553	0.0024	CcSEcCtD
Alosetron—Arrhythmia—Memantine—Alzheimer's disease	0.00055	0.00238	CcSEcCtD
Alosetron—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000547	0.00237	CcSEcCtD
Alosetron—Alopecia—Memantine—Alzheimer's disease	0.000544	0.00236	CcSEcCtD
Alosetron—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000538	0.00233	CcSEcCtD
Alosetron—Fatigue—Galantamine—Alzheimer's disease	0.000536	0.00232	CcSEcCtD
Alosetron—Malaise—Donepezil—Alzheimer's disease	0.000532	0.00231	CcSEcCtD
Alosetron—Alopecia—Rivastigmine—Alzheimer's disease	0.000532	0.00231	CcSEcCtD
Alosetron—Constipation—Galantamine—Alzheimer's disease	0.000531	0.0023	CcSEcCtD
Alosetron—Flatulence—Memantine—Alzheimer's disease	0.000528	0.00229	CcSEcCtD
Alosetron—Flatulence—Rivastigmine—Alzheimer's disease	0.000516	0.00224	CcSEcCtD
Alosetron—Cough—Donepezil—Alzheimer's disease	0.000515	0.00223	CcSEcCtD
Alosetron—Feeling abnormal—Galantamine—Alzheimer's disease	0.000512	0.00222	CcSEcCtD
Alosetron—Hypertension—Donepezil—Alzheimer's disease	0.000509	0.00221	CcSEcCtD
Alosetron—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000504	0.00218	CcSEcCtD
Alosetron—Myalgia—Donepezil—Alzheimer's disease	0.000502	0.00218	CcSEcCtD
Alosetron—Tremor—Memantine—Alzheimer's disease	0.000502	0.00218	CcSEcCtD
Alosetron—Anxiety—Donepezil—Alzheimer's disease	0.0005	0.00217	CcSEcCtD
Alosetron—Ill-defined disorder—Memantine—Alzheimer's disease	0.000497	0.00215	CcSEcCtD
Alosetron—Discomfort—Donepezil—Alzheimer's disease	0.000496	0.00215	CcSEcCtD
Alosetron—Dry mouth—Donepezil—Alzheimer's disease	0.000491	0.00213	CcSEcCtD
Alosetron—Tremor—Rivastigmine—Alzheimer's disease	0.000491	0.00213	CcSEcCtD
Alosetron—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000486	0.00211	CcSEcCtD
Alosetron—Confusional state—Donepezil—Alzheimer's disease	0.000485	0.0021	CcSEcCtD
Alosetron—Malaise—Memantine—Alzheimer's disease	0.000483	0.00209	CcSEcCtD
Alosetron—Infection—Donepezil—Alzheimer's disease	0.000478	0.00207	CcSEcCtD
Alosetron—Malaise—Rivastigmine—Alzheimer's disease	0.000473	0.00205	CcSEcCtD
Alosetron—Cough—Memantine—Alzheimer's disease	0.000467	0.00203	CcSEcCtD
Alosetron—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000465	0.00202	CcSEcCtD
Alosetron—Hypertension—Memantine—Alzheimer's disease	0.000462	0.002	CcSEcCtD
Alosetron—Hypersensitivity—Galantamine—Alzheimer's disease	0.000458	0.00198	CcSEcCtD
Alosetron—Cough—Rivastigmine—Alzheimer's disease	0.000457	0.00198	CcSEcCtD
Alosetron—Myalgia—Memantine—Alzheimer's disease	0.000456	0.00198	CcSEcCtD
Alosetron—Anxiety—Memantine—Alzheimer's disease	0.000454	0.00197	CcSEcCtD
Alosetron—Hypertension—Rivastigmine—Alzheimer's disease	0.000452	0.00196	CcSEcCtD
Alosetron—Discomfort—Memantine—Alzheimer's disease	0.000451	0.00195	CcSEcCtD
Alosetron—Myalgia—Rivastigmine—Alzheimer's disease	0.000446	0.00193	CcSEcCtD
Alosetron—Dry mouth—Memantine—Alzheimer's disease	0.000446	0.00193	CcSEcCtD
Alosetron—Asthenia—Galantamine—Alzheimer's disease	0.000446	0.00193	CcSEcCtD
Alosetron—Anxiety—Rivastigmine—Alzheimer's disease	0.000445	0.00193	CcSEcCtD
Alosetron—Confusional state—Memantine—Alzheimer's disease	0.000441	0.00191	CcSEcCtD
Alosetron—Discomfort—Rivastigmine—Alzheimer's disease	0.000441	0.00191	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000439	0.0019	CcSEcCtD
Alosetron—Dry mouth—Rivastigmine—Alzheimer's disease	0.000436	0.00189	CcSEcCtD
Alosetron—Infection—Memantine—Alzheimer's disease	0.000434	0.00188	CcSEcCtD
Alosetron—Confusional state—Rivastigmine—Alzheimer's disease	0.000431	0.00187	CcSEcCtD
Alosetron—Infection—Rivastigmine—Alzheimer's disease	0.000425	0.00184	CcSEcCtD
Alosetron—Skin disorder—Memantine—Alzheimer's disease	0.000425	0.00184	CcSEcCtD
Alosetron—Hyperhidrosis—Memantine—Alzheimer's disease	0.000423	0.00183	CcSEcCtD
Alosetron—Skin disorder—Rivastigmine—Alzheimer's disease	0.000415	0.0018	CcSEcCtD
Alosetron—Fatigue—Donepezil—Alzheimer's disease	0.000415	0.0018	CcSEcCtD
Alosetron—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000413	0.00179	CcSEcCtD
Alosetron—Pain—Donepezil—Alzheimer's disease	0.000412	0.00178	CcSEcCtD
Alosetron—Constipation—Donepezil—Alzheimer's disease	0.000412	0.00178	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000398	0.00173	CcSEcCtD
Alosetron—Feeling abnormal—Donepezil—Alzheimer's disease	0.000397	0.00172	CcSEcCtD
Alosetron—Vomiting—Galantamine—Alzheimer's disease	0.000395	0.00171	CcSEcCtD
Alosetron—Rash—Galantamine—Alzheimer's disease	0.000392	0.0017	CcSEcCtD
Alosetron—Dermatitis—Galantamine—Alzheimer's disease	0.000391	0.0017	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00039	0.00169	CcSEcCtD
Alosetron—Headache—Galantamine—Alzheimer's disease	0.000389	0.00169	CcSEcCtD
Alosetron—Urticaria—Donepezil—Alzheimer's disease	0.000382	0.00166	CcSEcCtD
Alosetron—Fatigue—Memantine—Alzheimer's disease	0.000377	0.00163	CcSEcCtD
Alosetron—Constipation—Memantine—Alzheimer's disease	0.000374	0.00162	CcSEcCtD
Alosetron—Pain—Memantine—Alzheimer's disease	0.000374	0.00162	CcSEcCtD
Alosetron—Nausea—Galantamine—Alzheimer's disease	0.000369	0.0016	CcSEcCtD
Alosetron—Fatigue—Rivastigmine—Alzheimer's disease	0.000369	0.0016	CcSEcCtD
Alosetron—Pain—Rivastigmine—Alzheimer's disease	0.000366	0.00159	CcSEcCtD
Alosetron—Constipation—Rivastigmine—Alzheimer's disease	0.000366	0.00159	CcSEcCtD
Alosetron—Feeling abnormal—Memantine—Alzheimer's disease	0.00036	0.00156	CcSEcCtD
Alosetron—Hypersensitivity—Donepezil—Alzheimer's disease	0.000355	0.00154	CcSEcCtD
Alosetron—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000352	0.00153	CcSEcCtD
Alosetron—Urticaria—Memantine—Alzheimer's disease	0.000347	0.00151	CcSEcCtD
Alosetron—Asthenia—Donepezil—Alzheimer's disease	0.000345	0.0015	CcSEcCtD
Alosetron—Urticaria—Rivastigmine—Alzheimer's disease	0.00034	0.00147	CcSEcCtD
Alosetron—Hypersensitivity—Memantine—Alzheimer's disease	0.000322	0.0014	CcSEcCtD
Alosetron—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000315	0.00137	CcSEcCtD
Alosetron—Asthenia—Memantine—Alzheimer's disease	0.000314	0.00136	CcSEcCtD
Alosetron—Asthenia—Rivastigmine—Alzheimer's disease	0.000307	0.00133	CcSEcCtD
Alosetron—Vomiting—Donepezil—Alzheimer's disease	0.000306	0.00133	CcSEcCtD
Alosetron—Rash—Donepezil—Alzheimer's disease	0.000304	0.00132	CcSEcCtD
Alosetron—Dermatitis—Donepezil—Alzheimer's disease	0.000303	0.00131	CcSEcCtD
Alosetron—Headache—Donepezil—Alzheimer's disease	0.000302	0.00131	CcSEcCtD
Alosetron—Nausea—Donepezil—Alzheimer's disease	0.000286	0.00124	CcSEcCtD
Alosetron—Vomiting—Memantine—Alzheimer's disease	0.000278	0.0012	CcSEcCtD
Alosetron—Rash—Memantine—Alzheimer's disease	0.000276	0.00119	CcSEcCtD
Alosetron—Dermatitis—Memantine—Alzheimer's disease	0.000275	0.00119	CcSEcCtD
Alosetron—Headache—Memantine—Alzheimer's disease	0.000274	0.00119	CcSEcCtD
Alosetron—Vomiting—Rivastigmine—Alzheimer's disease	0.000272	0.00118	CcSEcCtD
Alosetron—Rash—Rivastigmine—Alzheimer's disease	0.00027	0.00117	CcSEcCtD
Alosetron—Dermatitis—Rivastigmine—Alzheimer's disease	0.000269	0.00117	CcSEcCtD
Alosetron—Headache—Rivastigmine—Alzheimer's disease	0.000268	0.00116	CcSEcCtD
Alosetron—Nausea—Memantine—Alzheimer's disease	0.00026	0.00113	CcSEcCtD
Alosetron—Nausea—Rivastigmine—Alzheimer's disease	0.000254	0.0011	CcSEcCtD
Alosetron—CYP1A2—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000174	0.00577	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000174	0.00577	CbGpPWpGaD
Alosetron—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000174	0.00577	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000173	0.00575	CbGpPWpGaD
Alosetron—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000171	0.00569	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—CYP46A1—Alzheimer's disease	0.000169	0.0056	CbGpPWpGaD
Alosetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000167	0.00554	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000166	0.00552	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000166	0.00551	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000158	0.00525	CbGpPWpGaD
Alosetron—CYP2E1—Vitamin A and Carotenoid Metabolism—LPL—Alzheimer's disease	0.000154	0.00512	CbGpPWpGaD
Alosetron—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000151	0.00502	CbGpPWpGaD
Alosetron—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000151	0.00501	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000147	0.00489	CbGpPWpGaD
Alosetron—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000144	0.00479	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000144	0.00477	CbGpPWpGaD
Alosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000143	0.00473	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000141	0.00467	CbGpPWpGaD
Alosetron—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000136	0.00451	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000134	0.00445	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000133	0.00442	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000126	0.00419	CbGpPWpGaD
Alosetron—CYP1A2—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000123	0.00409	CbGpPWpGaD
Alosetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000122	0.00406	CbGpPWpGaD
Alosetron—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000121	0.004	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.000119	0.00394	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000117	0.00388	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000114	0.00378	CbGpPWpGaD
Alosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.00011	0.00365	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000109	0.00361	CbGpPWpGaD
Alosetron—CYP1A2—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000107	0.00355	CbGpPWpGaD
Alosetron—CYP1A2—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000106	0.00354	CbGpPWpGaD
Alosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000104	0.00347	CbGpPWpGaD
Alosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000103	0.00342	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP46A1—Alzheimer's disease	0.000101	0.00337	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000101	0.00335	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—MAOB—Alzheimer's disease	0.000101	0.00334	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP46A1—Alzheimer's disease	9.99e-05	0.00332	CbGpPWpGaD
Alosetron—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	9.95e-05	0.00331	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	9.9e-05	0.00329	CbGpPWpGaD
Alosetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	9.56e-05	0.00317	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	9.36e-05	0.00311	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	9.34e-05	0.0031	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—TF—Alzheimer's disease	9.25e-05	0.00307	CbGpPWpGaD
Alosetron—CYP1A2—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	9.22e-05	0.00306	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	8.79e-05	0.00292	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	8.78e-05	0.00292	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	8.72e-05	0.0029	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	8.63e-05	0.00286	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	8.46e-05	0.00281	CbGpPWpGaD
Alosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	8.17e-05	0.00271	CbGpPWpGaD
Alosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	8.05e-05	0.00267	CbGpPWpGaD
Alosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	7.95e-05	0.00264	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	7.93e-05	0.00263	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	7.82e-05	0.0026	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	7.71e-05	0.00256	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—PTGS1—Alzheimer's disease	7.62e-05	0.00253	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—CYP2D6—Alzheimer's disease	7.48e-05	0.00248	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	7.37e-05	0.00245	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	7.08e-05	0.00235	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	7.03e-05	0.00233	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	6.83e-05	0.00227	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	6.79e-05	0.00226	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	6.66e-05	0.00221	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	6.53e-05	0.00217	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.47e-05	0.00215	CbGpPWpGaD
Alosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	6.3e-05	0.00209	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	6.05e-05	0.00201	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	5.83e-05	0.00194	CbGpPWpGaD
Alosetron—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	5.52e-05	0.00183	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	5.48e-05	0.00182	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	5.36e-05	0.00178	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	5.26e-05	0.00175	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.19e-05	0.00172	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	5.04e-05	0.00168	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	4.93e-05	0.00164	CbGpPWpGaD
Alosetron—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	4.72e-05	0.00157	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	4.69e-05	0.00156	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	4.67e-05	0.00155	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	4.58e-05	0.00152	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	4.55e-05	0.00151	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	4.49e-05	0.00149	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.43e-05	0.00147	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—DHCR24—Alzheimer's disease	4.32e-05	0.00143	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	4.22e-05	0.0014	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	3.97e-05	0.00132	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.89e-05	0.00129	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CA4—Alzheimer's disease	3.67e-05	0.00122	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	3.65e-05	0.00121	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	3.54e-05	0.00117	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	3.47e-05	0.00115	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GAPDHS—Alzheimer's disease	3.45e-05	0.00115	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.42e-05	0.00114	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	3.41e-05	0.00113	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	3.41e-05	0.00113	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ATP5A1—Alzheimer's disease	3.27e-05	0.00109	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PLD3—Alzheimer's disease	3.12e-05	0.00104	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	3.04e-05	0.00101	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HSD17B10—Alzheimer's disease	2.99e-05	0.000995	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP46A1—Alzheimer's disease	2.88e-05	0.000957	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.83e-05	0.000941	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ND1—Alzheimer's disease	2.78e-05	0.000925	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	2.6e-05	0.000863	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.58e-05	0.000858	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.53e-05	0.000839	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.43e-05	0.000807	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.42e-05	0.000804	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.3e-05	0.000765	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CA4—Alzheimer's disease	2.21e-05	0.000733	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.2e-05	0.00073	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.2e-05	0.00073	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.17e-05	0.000721	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.16e-05	0.000717	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	2.11e-05	0.0007	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	2.08e-05	0.00069	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.06e-05	0.000684	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	2.03e-05	0.000674	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2e-05	0.000666	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.97e-05	0.000654	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.96e-05	0.00065	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.91e-05	0.000636	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.88e-05	0.000624	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.88e-05	0.000624	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.86e-05	0.000616	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.8e-05	0.000598	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TPI1—Alzheimer's disease	1.79e-05	0.000596	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CHAT—Alzheimer's disease	1.79e-05	0.000596	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.76e-05	0.000584	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.75e-05	0.000581	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.73e-05	0.000576	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MAOB—Alzheimer's disease	1.72e-05	0.000571	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.7e-05	0.000566	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.67e-05	0.000556	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GAPDH—Alzheimer's disease	1.66e-05	0.00055	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.64e-05	0.000543	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.6e-05	0.000532	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—A2M—Alzheimer's disease	1.6e-05	0.000531	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.52e-05	0.000505	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.51e-05	0.000501	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.5e-05	0.000497	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.45e-05	0.000481	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ACHE—Alzheimer's disease	1.39e-05	0.000462	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.39e-05	0.000461	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—INPP5D—Alzheimer's disease	1.38e-05	0.000457	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.37e-05	0.000456	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.34e-05	0.000444	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	1.3e-05	0.000433	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ENO1—Alzheimer's disease	1.3e-05	0.000433	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.29e-05	0.000429	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.29e-05	0.000428	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	1.28e-05	0.000425	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.26e-05	0.000419	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.26e-05	0.000419	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—BCHE—Alzheimer's disease	1.21e-05	0.000402	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.21e-05	0.000402	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.17e-05	0.00039	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.16e-05	0.000387	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.15e-05	0.000382	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	1.14e-05	0.00038	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.14e-05	0.000379	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.12e-05	0.000374	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	1.11e-05	0.000368	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.08e-05	0.000358	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.08e-05	0.000358	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.03e-05	0.000343	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1e-05	0.000333	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	9.95e-06	0.000331	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.84e-06	0.000327	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ACHE—Alzheimer's disease	9.79e-06	0.000325	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.75e-06	0.000324	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	9.67e-06	0.000321	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—A2M—Alzheimer's disease	9.61e-06	0.000319	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	9.55e-06	0.000317	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	9.51e-06	0.000316	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ENO1—Alzheimer's disease	9.17e-06	0.000305	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	9.17e-06	0.000305	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	8.99e-06	0.000299	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—LPL—Alzheimer's disease	8.7e-06	0.000289	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.57e-06	0.000285	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—BCHE—Alzheimer's disease	8.53e-06	0.000283	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ACHE—Alzheimer's disease	8.36e-06	0.000278	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TPI1—Alzheimer's disease	8.32e-06	0.000276	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CHAT—Alzheimer's disease	8.32e-06	0.000276	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	8.27e-06	0.000275	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	8.04e-06	0.000267	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.98e-06	0.000265	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.89e-06	0.000262	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ENO1—Alzheimer's disease	7.84e-06	0.00026	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	7.84e-06	0.00026	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	7.83e-06	0.00026	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.8e-06	0.000259	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	7.69e-06	0.000255	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7.68e-06	0.000255	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—A2M—Alzheimer's disease	7.42e-06	0.000246	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CALM1—Alzheimer's disease	7.32e-06	0.000243	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—APOE—Alzheimer's disease	7.29e-06	0.000242	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—BCHE—Alzheimer's disease	7.29e-06	0.000242	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CAV1—Alzheimer's disease	7.22e-06	0.00024	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	6.87e-06	0.000228	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.74e-06	0.000224	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.72e-06	0.000223	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.69e-06	0.000222	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	6.66e-06	0.000221	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.45e-06	0.000214	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.38e-06	0.000212	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARG—Alzheimer's disease	6.35e-06	0.000211	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—INS—Alzheimer's disease	6.23e-06	0.000207	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—LPL—Alzheimer's disease	6.12e-06	0.000203	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.05e-06	0.000201	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.05e-06	0.000201	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.93e-06	0.000197	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	5.74e-06	0.000191	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	5.72e-06	0.00019	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.62e-06	0.000187	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	5.51e-06	0.000183	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NOS3—Alzheimer's disease	5.46e-06	0.000181	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.31e-06	0.000176	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—LPL—Alzheimer's disease	5.23e-06	0.000174	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CALM1—Alzheimer's disease	5.15e-06	0.000171	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.14e-06	0.000171	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—APOE—Alzheimer's disease	5.13e-06	0.00017	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CAV1—Alzheimer's disease	5.08e-06	0.000169	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	5e-06	0.000166	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	4.71e-06	0.000156	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.47e-06	0.000148	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.43e-06	0.000147	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.41e-06	0.000147	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CALM1—Alzheimer's disease	4.4e-06	0.000146	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—APOE—Alzheimer's disease	4.38e-06	0.000146	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—INS—Alzheimer's disease	4.38e-06	0.000146	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CAV1—Alzheimer's disease	4.34e-06	0.000144	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.04e-06	0.000134	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.84e-06	0.000128	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.82e-06	0.000127	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—INS—Alzheimer's disease	3.74e-06	0.000124	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.63e-06	0.000121	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.51e-06	0.000117	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.39e-06	0.000113	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.38e-06	0.000112	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.35e-06	0.000111	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NOS3—Alzheimer's disease	3.28e-06	0.000109	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	3e-06	9.97e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.95e-06	9.78e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—INS—Alzheimer's disease	2.89e-06	9.6e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.53e-06	8.42e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKT1—Alzheimer's disease	2.51e-06	8.34e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.32e-06	7.7e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.77e-06	5.87e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.51e-06	5.01e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.16e-06	3.87e-05	CbGpPWpGaD
